Alx oncology to host virtual r&d day on march 5, 2025

South san francisco, calif., feb. 18, 2025 (globe newswire) -- alx oncology holdings inc., (“alx oncology” or the “company”) (nasdaq: alxo), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients' lives, today announced that it will host a virtual research and development (r&d) day webcast on wednesday, march 5, 2025, at 6:00 a.m.
ALXO Ratings Summary
ALXO Quant Ranking